Summary
37 / 100 · Bulios Score
What speaks for it
- It has no debt and holds $136.4M in cash.
- It beat profit estimates 7 times in the last 8 quarters.
What to watch
- The company made a loss over the last 12 months.
- Revenue fell by 2.1% a year over the last 3 years.
- It passes only 1 of the 9 points of the Piotroski financial health test.
- Analysts expect revenue to fall by 11% this fiscal year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 6.4% a year over 5 years. Over the last 3 years it fell by 2.1% a year. For the next fiscal year analysts expect revenue to fall by 11%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $446.4M.
Profitability in detailIs it financially healthy?
YesIt has no debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 6
- Hold 15
- Sell 7
Today's price within the analysts' price targets
The average target of $9.67 is 14% below today's price. 21% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2024By product
- License and Service 90%
- Professional Services 10%
By region
- North America 87%
- EMEA 12%
- Asia Pacific 1.2%
- Rest Of World 0.4%
License and Service brings in 90% of revenue.
Segments in detail